1 Min Read
Feb 8 (Reuters) - Veloxis Pharmaceuticals A/S:
* Agreed to amend and restate terms of its previously announced loan and security agreement with Lundbeckfond Invest A/S and Novo A/S.
* Terms of amended and restated agreement make available an additional $10 million in financing at an interest rate of 12 pct, payable annually in arrears Source text for Eikon:
Further company coverage: (Gdynia Newsroom)